1. Home
  2. NRSN vs IPWR Comparison

NRSN vs IPWR Comparison

Compare NRSN & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • IPWR
  • Stock Information
  • Founded
  • NRSN 2017
  • IPWR 2007
  • Country
  • NRSN Israel
  • IPWR United States
  • Employees
  • NRSN N/A
  • IPWR N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • IPWR Industrial Machinery/Components
  • Sector
  • NRSN Health Care
  • IPWR Industrials
  • Exchange
  • NRSN Nasdaq
  • IPWR Nasdaq
  • Market Cap
  • NRSN 45.3M
  • IPWR 42.1M
  • IPO Year
  • NRSN 2021
  • IPWR 2013
  • Fundamental
  • Price
  • NRSN $1.91
  • IPWR $4.70
  • Analyst Decision
  • NRSN Buy
  • IPWR Hold
  • Analyst Count
  • NRSN 2
  • IPWR 1
  • Target Price
  • NRSN $14.00
  • IPWR N/A
  • AVG Volume (30 Days)
  • NRSN 427.0K
  • IPWR 63.3K
  • Earning Date
  • NRSN 07-15-2025
  • IPWR 08-13-2025
  • Dividend Yield
  • NRSN N/A
  • IPWR N/A
  • EPS Growth
  • NRSN N/A
  • IPWR N/A
  • EPS
  • NRSN N/A
  • IPWR N/A
  • Revenue
  • NRSN N/A
  • IPWR $19,296.00
  • Revenue This Year
  • NRSN N/A
  • IPWR N/A
  • Revenue Next Year
  • NRSN N/A
  • IPWR $5,900.00
  • P/E Ratio
  • NRSN N/A
  • IPWR N/A
  • Revenue Growth
  • NRSN N/A
  • IPWR N/A
  • 52 Week Low
  • NRSN $0.51
  • IPWR $3.77
  • 52 Week High
  • NRSN $2.60
  • IPWR $9.69
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 48.94
  • IPWR 53.15
  • Support Level
  • NRSN $1.81
  • IPWR $3.81
  • Resistance Level
  • NRSN $1.96
  • IPWR $4.77
  • Average True Range (ATR)
  • NRSN 0.20
  • IPWR 0.38
  • MACD
  • NRSN -0.08
  • IPWR 0.05
  • Stochastic Oscillator
  • NRSN 19.10
  • IPWR 85.58

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About IPWR Ideal Power Inc.

Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

Share on Social Networks: